In line with these results, whole-body SIRT2 deletion or inhibition promoted inflammatory responses by increasing NF-κB acetylation and creating a pro-inflammatory milieu in a mouse model of colitis [84], in obese-septic mice [43], and in a mouse model of traumatic brain injury [44]. Here, NFKB1 is linked to colitis.